Berger A

Pain and Palliative Care, National Institutes of Health Clinical Center, Bethesda, MD, USA.

5 papers

ArticlePsilocybin

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.

Zia FZ, Baumann MH, Belouin SJ +7

Europe PMC2023
ArticlePsilocybin

National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.

Xi D, Berger A, Shurtleff D +2

Europe PMC2023
ArticlePsilocybin

Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.

Shnayder S, Ameli R, Sinaii N +2

Europe PMC2023
ArticlePsilocybin

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.

Henningfield JE, Coe MA, Griffiths RR +10

Europe PMC2022
ArticlePsilocybin

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.

Belouin SJ, Averill LA, Henningfield JE +7

Europe PMC2022